INS and Insulin resistance: Initial conjecture that this elevation is due to rapamycin-driven insulin resistance [reviewed in 10, 11, 14] is presently tempered by a growing body of evidence that, depending upon the mouse model, rapamycin can have no effect on insulin resistance [12, 13] or can actually promote insulin sensitivity [17, 34].